ABCL—AbCellera Biologics Inc. Common SharesEarnings
NASDAQ·HealthcareData sourced from Finnhub (quotes, earnings calendar, news) and Yahoo Finance (daily closing prices). Source evidence retrieved Nov 15, 2026 23:07 UTC. No upcoming date available. Read the methodology.
ABCL delayed price change and context
ABCL (AbCellera Biologics Inc. Common Shares) — the delayed price is temporarily unavailable. No price move or cause is inferred.
Delayed quote
Loading…
Company overview
- Sector
- Healthcare
- Industry
- Life Sciences Tools & Services
- Exchange
- NASDAQ
- Market cap
- $3.6B
- Report time
- —
AbCellera Biologics Inc. Common Shares is listed on NASDAQ in the healthcare sector. No upcoming earnings date is currently scheduled.
Price history
Loading…
AbCellera Biologics Inc. Common Shares earnings results · Q3 2026
Reported Nov 9, 2026EPS estimate
$-0.17
EPS actual
$-0.13
Surprise
+24.2%
Price move
-0.3%
Close Nov 9 ($12.50) → close Nov 10 ($12.46) · end-of-day prices
What ABCL’s latest earnings results show
AbCellera Biologics Inc. Common Shares reported EPS of $-0.13 for Q3 2026. This was $0.04 above the $-0.17 consensus estimate. An EPS beat alone does not establish revenue growth, stronger guidance or an attractive valuation.
Source: Finnhub reported EPS and consensus estimates. Fiscal quarter-end dates are not announcement dates. Price reactions use daily closes, not intraday returns.
Recent posts · ABCL
All postsNo blog posts covering ABCL yet.
AI Stock Analysis is a Pro feature
Get an AI-generated breakdown of every earnings setup — beat history, EPS trend, and what to watch into the print.
Unlock with ProEarnings history · EPS estimate vs actual
Last 1 quarters · Free preview · Source: Finnhub
| Quarter | Fiscal period end | Reported | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|---|---|
| Q3 '26 | 2026-09-30 | 2026-11-09FinnhubRetrieved 2026-11-15 23:07 UTC | -0.17 | -0.13 | +24.2% |
Post-earnings price reaction · last 4 quarters
1-day = close after announcement vs close before. 5-day = close 5 trading days after vs close before. Projection extrapolates average magnitude.
AI summary · latest 8-K earnings release
Generated from the latest SEC EDGAR filing
Summarizing 8-K release… first run can take 10–20s.
Catalyst timeline
Upcoming and recent market-moving events for ABCL · plus key macro context
Surprise prints repriced rate-cut odds last 3 of 4 releases. Bond yields and rate-sensitive sectors most exposed.
Highest-impact macro print of the cycle. SPX implied move 1.4%, semis 2.3%.
Latest news · ABCL
Headlines from the past 14 days · Source: Finnhub
ABCL discussion
ABCL earnings FAQ
- When does ABCL report earnings?
- AbCellera Biologics Inc. Common Shares (ABCL) has no upcoming provider date available here. This does not mean the company has not announced one.
- What time does ABCL report earnings?
- ABCL historically reports during quarterly earnings season. Check the calendar for the confirmed BMO or AMC time for the next print.
- What exchange is ABCL listed on?
- AbCellera Biologics Inc. Common Shares (ABCL) trades on the NASDAQ in the Healthcare sector.
- How can I track ABCL earnings history?
- The latest two reported quarters are publicly available. Pro subscribers can access up to eight quarters and deeper analysis.
What to listen for on the ABCL earnings call
Sector- and ticker-specific items active traders track on AbCellera Biologics Inc. Common Shares's quarterly call — beyond the headline EPS and revenue beat.
- Drug / device segment revenue and pricing
- Pipeline read-outs and FDA milestones
- Medical-loss ratio (for payers)
- Updated full-year guidance range
ABCL peer context
How ABCL compares to other large healthcare names on the calendar.
| Ticker | Company | Exchange | Sector |
|---|---|---|---|
ABCL ABCL | AbCellera Biologics Inc. Common Shares | NASDAQ | Healthcare |
AAPG AAPG | Ascentage Pharma Group International American Depository Shares | NASDAQ | Healthcare |
AARD AARD | Aardvark Therapeutics Inc | NASDAQ | Healthcare |
ABBV ABBV | AbbVie Inc | NYSE | Healthcare |
ABEO ABEO | Abeona Therapeutics Inc | NASDAQ | Healthcare |
More Healthcare earnings
Related companies in the Healthcare sector
About ABCL earnings
AbCellera Biologics Inc. Common Shares (ABCL) is a healthcare company listed on the NASDAQ. No next release date is available here. . Earnings Compass tracks the report time, analyst EPS and revenue consensus, and the post-release price reaction so active traders can size positions and set alerts ahead of the print.
On reporting day, the two numbers that move ABCL most are the headline EPS and the forward guidance. EPS (earnings per share) measures profit per outstanding share; a beat of analyst consensus often triggers price-target upgrades, while a miss can wipe out months of gains in a single session. The forward guidance management issues for the next quarter frequently overrides the headline — a beat-and-guide-down quarter still sells off, and a miss with a stronger outlook can rally. Active traders also watch the whisper number — the unofficial bar ABCL actually has to clear for the stock to rally on the print.
For a step-by-step playbook on parsing the release, see our guides on reading an earnings report and trading earnings season. If you're new to the calendar workflow, the earnings calendar guide covers how to filter the day's reports by sector and market cap to surface the names that actually move your book.
Add ABCL to your watchlist to receive an alert when the date is confirmed and again when results hit. You can also browse the full Healthcare sector page for the rest of the upcoming reports in this group, or the full earnings calendar for everything reporting this week.